Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours

Int J Cancer. 1995 Mar 3;60(5):645-51. doi: 10.1002/ijc.2910600514.

Abstract

Transforming growth-factor-alpha (TGF-alpha) is a 50-amino-acid polypeptide that binds to the epidermal growth factor (EGF) receptor and stimulates cell growth. It has been suggested that enhanced production of TGF-alpha and EGF receptors by tumour cells promote tumour-cell growth by autocrine mechanisms. In the present study we have investigated the expression of TGF-alpha and EGF receptors in human neuroendocrine tumours, including midgut carcinoid tumours, phaeochromocytomas and medullary thyroid carcinomas. TGF-alpha expression was demonstrated in biopsies of all tumours examined (n = 30) and EGF receptors in a majority of tumours by Northern analysis and/or immunocytochemistry. Expression of TGF-alpha and EGF receptors was also demonstrated in primary cultures of tumour cells. Carcinoid tumours and phaeochromocytomas in culture secreted detectable amounts of TGF-alpha into the culture medium (400-700 pM). The amount of secreted TGF-alpha could be suppressed by octreotide treatment in individual tumours. Administration of exogenous TGF-alpha stimulated carcinoid tumour growth in vitro as determined by the DNA contents of cell cultures. The growth-stimulatory effect of TGF-alpha could be partially blocked by the use of neutralizing anti-EGF receptor monoclonal antibodies (MAbs). In conclusion, several human neuroendocrine tumours express both TGF-alpha and EGF receptors in in vivo and in vitro, suggesting that TGF-alpha may regulate tumour-cell growth by autocrine mechanisms.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Gland Neoplasms / genetics
  • Adrenal Gland Neoplasms / pathology
  • Aged
  • Antibodies, Monoclonal / immunology
  • Autoreceptors / drug effects
  • Autoreceptors / immunology
  • Autoreceptors / physiology
  • Carcinoid Tumor / genetics
  • Carcinoid Tumor / secondary
  • Carcinoma, Medullary / genetics
  • Carcinoma, Medullary / pathology
  • Cell Division / drug effects
  • DNA, Neoplasm / genetics
  • ErbB Receptors / biosynthesis*
  • ErbB Receptors / drug effects
  • ErbB Receptors / genetics
  • ErbB Receptors / immunology
  • ErbB Receptors / physiology
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Liver Neoplasms / genetics
  • Liver Neoplasms / secondary
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology
  • Neuroendocrine Tumors / genetics*
  • Neuroendocrine Tumors / pathology
  • Paraganglioma / genetics
  • Paraganglioma / pathology
  • Pheochromocytoma / genetics
  • Pheochromocytoma / pathology
  • RNA, Messenger / analysis
  • RNA, Neoplasm / analysis
  • Retroperitoneal Neoplasms / genetics
  • Retroperitoneal Neoplasms / pathology
  • Thyroid Neoplasms / genetics
  • Thyroid Neoplasms / pathology
  • Transforming Growth Factor alpha / biosynthesis*
  • Transforming Growth Factor alpha / genetics
  • Transforming Growth Factor alpha / pharmacology
  • Transforming Growth Factor alpha / physiology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Antibodies, Monoclonal
  • Autoreceptors
  • DNA, Neoplasm
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Transforming Growth Factor alpha
  • ErbB Receptors